 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dorothy Clarke

 Dorothy Clarke

 WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new...

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

Final stage of technical evaluation near completion in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company Expanded and strengthened Comera's global patent...

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

Comera Life Sciences Presents SQore  Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA  Get Free Report) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totalling...

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Short Interest Update

WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The most promising penny stocks combine strong share price targets and improving fundamentals moving forward.
The post These Are the ONLY 7 Penny Stocks to Consider in August 2023 appeared first on InvestorPlace...

These Are the ONLY 7 Penny Stocks to Consider in August 2023

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences ...

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA  Get Free Report) insider Robert Patrick Mahoney acquired 20,000 shares of the stock in a transaction dated Monday, August 14th. The stock was...

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Insider Buys $12,600.00 in Stock

WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced a significant expansion of its SQore patent portfolio ...

WOBURN, Mass., Aug. 08, 2023...

WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced that it has executed a definitive agreement to complete a...

Comera Life Sciences Announces $4.1 Million Private Placement

Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.

Market Cap	$3.07M
Volume (M)	124,823.00
52-Wk High	$0.128
52-Wk Low	$0.03

CMRA Comera Life Sciences Holdings, Inc.

About

Feed

News

Sentiment

Fundamentals